Title | Metabolism Assays Market worth $2.1 billion by 2028 |
URL | https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=135163479 |
Category | Fitness Health --> Health Articles |
Meta Keywords | Global Metabolism Assays Market, Metabolism Assays Industry, Metabolism Assays Market Size, Metabolism Assays Market Growth, Metabolism Assays Market Trends |
Meta Description | Merck KGaA (Germany), Thermo Fisher (US), Abcam Plc. (UK), Agilent Technologies Inc. (US), and Kaneka Eurogentec S.A. (Belgium). |
Owner | Healthcare101 |
Description |
Metabolism Assays Market in terms of revenue was estimated to be worth $1.4 billion in 2023 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government to promote metabolic & disease research, innovation in metabolism assays technology by integrating with wearable devices, increase in prevalence of metabolic disorders such as diabetes and obesity, and adoption of metabolism assays by fitness and sports industries. |